MEDSCI (02415) announced its financial results for the year ended December 31, 2025. The group recorded revenue of 270 million yuan, representing a year-on-year increase of 3.74%. Profit attributable to owners of the parent company was 17.937 million yuan, a decrease of 28.16% compared to the previous year. Basic earnings per share stood at 0.03 yuan.